Gene · 8115
Papers1,926
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
181 to 200 of 1,926
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Targeting mRNA translation aberrations: A novel approach for therapy in chronic lymphocytic leukemia. | Cancer Commun (Lond) | 2023 | 37803910 | PubTator, text mining | PubMed |
| TCL1A+ B cells predict prognosis in triple-negative breast cancer through integrative analysis of single-cell and bulk transcriptomic data. | Open Life Sci | 2023 | 37791059 | PubTator, text mining | PubMed |
| Advances of autoimmune rheumatic diseases related to malignant tumors. | Inflamm Res | 2023 | 37768354 | PubTator, text mining | PubMed |
| Leukaemic Presentation of Small-Cell Alk-Positive Anaplastic Large Cell Lymphoma in a Young Woman-Report of a Case with 9-Year Survival. | Medicina (Kaunas) | 2023 | 37763746 | PubTator, text mining | PubMed |
| A Comparison of the Fifth World Health Organization and the International Consensus Classifications of Mature T-Cell Lymphomas. | Int J Mol Sci | 2023 | 37762472 | PubTator, text mining | PubMed |
| Interactions between the DNA Damage Response and the Telomere Complex in Carcinogenesis: A Hypothesis. | Curr Issues Mol Biol | 2023 | 37754262 | PubTator, text mining | PubMed |
| Single-cell RNA sequencing shows the immune cell landscape in the kidneys of patients with idiopathic membranous nephropathy. | Front Immunol | 2023 | 37731504 | PubTator, text mining | PubMed |
| Discovery of neutralizing SARS-CoV-2 antibodies enriched in a unique antigen specific B cell cluster. | PLoS One | 2023 | 37729215 | PubTator, text mining | PubMed |
| Discovery of a non-covalent ligand for Rpn-13, a therapeutic target for hematological cancers. | Bioorg Med Chem Lett | 2023 | 37714498 | PubTator, text mining | PubMed |
| DMRT1 regulates human germline commitment. | Nat Cell Biol | 2023 | 37709822 | PubTator, text mining | PubMed |
| Analysis of DNA methylation at birth and in childhood reveals changes associated with season of birth and latitude. | Clin Epigenetics | 2023 | 37697338 | PubTator, text mining | PubMed |
| Exploration of Key Immune-Related Transcriptomes Associated with Doxorubicin-Induced Cardiotoxicity in Patients with Breast Cancer. | Cardiovasc Toxicol | 2023 | 37684436 | PubTator, text mining | PubMed |
| The regulatory role of cancer stem cell marker gene CXCR4 in the growth and metastasis of gastric cancer. | NPJ Precis Oncol | 2023 | 37679408 | PubTator, text mining | PubMed |
| Single-cell multi-omics topic embedding reveals cell-type-specific and COVID-19 severity-related immune signatures. | Cell Rep Methods | 2023 | 37671028 | PubTator, text mining | PubMed |
| An integrated analysis of dysregulated SCD1 in human cancers and functional verification of miR-181a-5p/SCD1 axis in esophageal squamous cell carcinoma. | Comput Struct Biotechnol J | 2023 | 37664175 | PubTator, text mining | PubMed |
| 18F-FDG PET/CT findings in a patient with blastic plasmacytoid dendritic cell neoplasm and post-transplant lymphoproliferative disorder after hematopoietic stem cell transplantation: a case report. | Front Med (Lausanne) | 2023 | 37663666 | PubTator, text mining | PubMed |
| Venetoclax Combined with Azacytidine Can Be a First-line Treatment Option for Elderly Blastic Plasmacytoid Dendritic Cell Neoplasm. | Intern Med | 2023 | 37661416 | PubTator, text mining | PubMed |
| Frontline Hyper-CVAD Plus Venetoclax for Pediatric Blastic Plasmacytoid Dendritic Cell Neoplasm. | J Pediatr Hematol Oncol | 2023 | 37661300 | PubTator, text mining | PubMed |
| Novel transcriptomic signatures associated with premature kidney allograft failure. | EBioMedicine | 2023 | 37660534 | PubTator, text mining | PubMed |
| Ocular and neural genes jointly regulate the visuospatial working memory in ADHD children. | Behav Brain Funct | 2023 | 37658396 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/8115/papers?page=10